癌症中心乳腺影像二次意见复核:是否值得?
回顾200例在社区机构接受超声和MRI并提交癌症中心二次意见复核的乳腺影像研究,28%(95%CI 21-34%)的病例解读发生改变,13%(95%CI 9-18%)导致重大管理改变,新活检发现5%(95%CI 2-9%)恶性肿瘤,避免4%(95%CI 2-8%)不必要活检,作者认为二次意见复核影响临床管理并增加患者护理价值。
要点
- 社区机构乳腺超声和MRI二次意见复核使28%的病例解读发生改变。
- 二次意见复核导致13%的病例发生重大管理改变。
- 新活检发现5%恶性肿瘤和2%高危病变,避免4%不必要活检。
核心结论
- 二次意见复核影响临床管理并增加患者护理价值。
研究设计与样本
- 回顾性研究,纳入200例在社区机构接受超声和MRI并于2014年1月至4月提交癌症中心二次意见复核的患者,以癌症中心组织病理学结果为参考标准。
诊断标准与关键数值
- 二次意见复核显示55例(28%;95% CI,21-34%)解读发生改变。
- 26条建议(13%;95% CI,9-18%)导致重大管理改变。
- 20例新活检产生10例恶性肿瘤(5%;95% CI,2-9%)和4例高危病变(2%;95% CI,1-5%)。
- 10例新活检证实恶性肿瘤的患者中6例(60%)手术管理改为乳房切除术。
- 基于影像学良性解读避免8例活检(4%;95% CI,2-8%),1年随访未发现病变。
临床应用与阅片要点
- 作者认为二次意见复核影响临床管理并增加患者护理价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Second-opinion review of breast imaging studies can be a time-consuming and labor-intensive process. The purpose of this investigation was to determine whether reinterpretation of studies obtained at institutions outside a cancer center influences clinical management, specifically by revealing additional cancer and preventing unnecessary biopsy.
MATERIALS AND METHODS: A review was conducted of breast imaging studies of 200 patients who underwent ultrasound and MRI at community facilities and had the images submitted for second opinions at a cancer center between January and April 2014. Each case was evaluated for concordance between the original report and the second-opinion interpretation. Second-opinion review resulting in the recommendation and performance of new biopsies was further subdivided into benign, high-risk, and malignant categories based on the histopathologic results obtained at the cancer center.
RESULTS: Second-opinion review of the 200 cases showed a change in interpretation in 55 cases (28%; 95% CI, 21-34%). Overall, 26 recommendations (13%; 95% CI, 9-18%) led to a major change in management. Twenty new biopsies were performed, yielding 10 malignancies (5%; 95% CI, 2-9%) and four high-risk lesions (2%; 95% CI, 1-5%). Surgical management was changed to mastectomy for 6 of 10 patients (60%) with new sites of biopsy-proven malignancy. Eight biopsies were averted (4%; 95% CI, 2-8%) on the basis of benign interpretation of the imaging findings, and no disease was found at 1-year follow-up evaluation.
CONCLUSION: Reinterpretation of studies obtained outside a cancer center resulted in a change in interpretation in more than one-fourth of submitted studies. Additional cancer was detected in 5% of patients, and biopsy was averted for 4%. The practice of second-opinion review influences clinical management and adds value to patient care.
引用
- Coffey K, D'Alessio D, Keating DM, et al. Second-Opinion Review of Breast Imaging at a Cancer Center: Is It Worthwhile? AJR Am J Roentgenol. 2017. PMID: 28301207. doi:10.2214/AJR.16.16871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。